151 related articles for article (PubMed ID: 32139504)
21. The use of ¹⁸F-BCPP-EF as a PET probe for complex I activity in the brain.
Tsukada H
Methods Enzymol; 2014; 547():417-31. PubMed ID: 25416368
[TBL] [Abstract][Full Text] [Related]
22. Effects of acetaminophen on mitochondrial complex I activity in the rat liver and kidney: a PET study with
Ohba H; Kanazawa M; Kakiuchi T; Tsukada H
EJNMMI Res; 2016 Dec; 6(1):82. PubMed ID: 27873239
[TBL] [Abstract][Full Text] [Related]
23. Quantitative longitudinal interrelationships between brain metabolism and amyloid deposition during a 2-year follow-up in patients with early Alzheimer's disease.
Förster S; Yousefi BH; Wester HJ; Klupp E; Rominger A; Förstl H; Kurz A; Grimmer T; Drzezga A
Eur J Nucl Med Mol Imaging; 2012 Dec; 39(12):1927-36. PubMed ID: 22926714
[TBL] [Abstract][Full Text] [Related]
24. BCPP compounds, PET probes for early therapeutic evaluations, specifically bind to mitochondrial complex I.
Kazami S; Nishiyama S; Kimura Y; Itoh H; Tsukada H
Mitochondrion; 2019 May; 46():97-102. PubMed ID: 29563046
[TBL] [Abstract][Full Text] [Related]
25. The Association of Glucose Metabolism and Eigenvector Centrality in Alzheimer's Disease.
Adriaanse SM; Wink AM; Tijms BM; Ossenkoppele R; Verfaillie SC; Lammertsma AA; Boellaard R; Scheltens P; van Berckel BN; Barkhof F
Brain Connect; 2016 Feb; 6(1):1-8. PubMed ID: 26414628
[TBL] [Abstract][Full Text] [Related]
26. Non-invasive evaluation of neuroprotective drug candidates for cerebral infarction by PET imaging of mitochondrial complex-I activity.
Fukuta T; Asai T; Ishii T; Koide H; Kiyokawa C; Hashimoto M; Kikuchi T; Shimizu K; Harada N; Tsukada H; Oku N
Sci Rep; 2016 Jul; 6():30127. PubMed ID: 27440054
[TBL] [Abstract][Full Text] [Related]
27. Comparing α7 nicotinic acetylcholine receptor binding, amyloid-β deposition, and mitochondria complex-I function in living brain: A PET study in aged monkeys.
Nishiyama S; Ohba H; Kanazawa M; Kakiuchi T; Tsukada H
Synapse; 2015 Oct; 69(10):475-83. PubMed ID: 26234533
[TBL] [Abstract][Full Text] [Related]
28. Sensitive and early detection of mitochondrial dysfunction in the liver of NASH model mice by PET imaging with
Sakai T; Ohba H; Nishiyama S; Kakiuchi T; Inoue O; Tsukada H
EJNMMI Res; 2018 Jul; 8(1):61. PubMed ID: 30014266
[TBL] [Abstract][Full Text] [Related]
29. Brain metabolic correlates of CSF Tau protein in a large cohort of Alzheimer's disease patients: A CSF and FDG PET study.
Chiaravalloti A; Barbagallo G; Ricci M; Martorana A; Ursini F; Sannino P; Karalis G; Schillaci O
Brain Res; 2018 Jan; 1678():116-122. PubMed ID: 29066367
[TBL] [Abstract][Full Text] [Related]
30. Amyloid load but not regional glucose metabolism predicts conversion to Alzheimer's dementia in a memory clinic population.
Frings L; Hellwig S; Bormann T; Spehl TS; Buchert R; Meyer PT
Eur J Nucl Med Mol Imaging; 2018 Jul; 45(8):1442-1448. PubMed ID: 29546632
[TBL] [Abstract][Full Text] [Related]
31. Alzheimer Disease and Mild Cognitive Impairment: Integrated Pulsed Arterial Spin-Labeling MRI and
Riederer I; Bohn KP; Preibisch C; Wiedemann E; Zimmer C; Alexopoulos P; Förster S
Radiology; 2018 Jul; 288(1):198-206. PubMed ID: 29762090
[TBL] [Abstract][Full Text] [Related]
32. Visualizing mitochondrial (dys)function using positron emission tomography imaging.
Srivastava A; Prasad PV
Kidney Int; 2020 Jul; 98(1):51-53. PubMed ID: 32571489
[TBL] [Abstract][Full Text] [Related]
33. Longitudinal changes of tau PET imaging in relation to hypometabolism in prodromal and Alzheimer's disease dementia.
Chiotis K; Saint-Aubert L; Rodriguez-Vieitez E; Leuzy A; Almkvist O; Savitcheva I; Jonasson M; Lubberink M; Wall A; Antoni G; Nordberg A
Mol Psychiatry; 2018 Jul; 23(7):1666-1673. PubMed ID: 28507319
[TBL] [Abstract][Full Text] [Related]
34. Mitochondrial complex I density is associated with IQ and cognition in cognitively healthy adults: an in vivo [
Shatalina E; Whitehurst TS; Onwordi EC; Gilbert BJ; Rizzo G; Whittington A; Mansur A; Tsukada H; Marques TR; Natesan S; Rabiner EA; Wall MB; Howes OD
EJNMMI Res; 2024 Apr; 14(1):41. PubMed ID: 38632153
[TBL] [Abstract][Full Text] [Related]
35. Cerebrospinal fluid lactate levels and brain [18F]FDG PET hypometabolism within the default mode network in Alzheimer's disease.
Liguori C; Chiaravalloti A; Sancesario G; Stefani A; Sancesario GM; Mercuri NB; Schillaci O; Pierantozzi M
Eur J Nucl Med Mol Imaging; 2016 Oct; 43(11):2040-9. PubMed ID: 27221635
[TBL] [Abstract][Full Text] [Related]
36. Brain metabolic patterns in patients with suspected non-Alzheimer's pathophysiology (SNAP) and Alzheimer's disease (AD): is [
Chiaravalloti A; Barbagallo G; Martorana A; Castellano AE; Ursini F; Schillaci O
Eur J Nucl Med Mol Imaging; 2019 Aug; 46(9):1796-1805. PubMed ID: 31201430
[TBL] [Abstract][Full Text] [Related]
37. [Molecular neuroimaging in the study of cognitive impairment: contribution of the cerebral blood flow SPECT with 99mTc-HMPAO and 18F-FDG PET/CT scan].
Banzo I; Quirce R; Martínez-Rodríguez I; Jiménez-Bonilla J; Portilla-Quattrociocchi H; Medina-Quiroz P; Ortega F; Rodríguez E; Mateo I; Vázquez-Higuera JL; de Arcocha M; Carril JM
Rev Esp Med Nucl; 2011; 30(5):301-6. PubMed ID: 21640440
[TBL] [Abstract][Full Text] [Related]
38. Parallel ICA of FDG-PET and PiB-PET in three conditions with underlying Alzheimer's pathology.
Laforce R; Tosun D; Ghosh P; Lehmann M; Madison CM; Weiner MW; Miller BL; Jagust WJ; Rabinovici GD
Neuroimage Clin; 2014; 4():508-16. PubMed ID: 24818077
[TBL] [Abstract][Full Text] [Related]
39. Voxel-based analysis of Alzheimer's disease PET imaging using a triplet of radiotracers: PIB, FDDNP, and FDG.
Shin J; Lee SY; Kim SJ; Kim SH; Cho SJ; Kim YB
Neuroimage; 2010 Aug; 52(2):488-96. PubMed ID: 20385246
[TBL] [Abstract][Full Text] [Related]
40. In vivo positron emission tomography imaging of mitochondrial abnormalities in a mouse model of tauopathy.
Barron AM; Ji B; Fujinaga M; Zhang MR; Suhara T; Sahara N; Aoki I; Tsukada H; Higuchi M
Neurobiol Aging; 2020 Oct; 94():140-148. PubMed ID: 32623260
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
